Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A BALL

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
British Journal of Pharmacology|October 1, 1994
Parallel tolerance between platelet cyclic GMP and preload effects of nitroglycerin in anaesthetized mini-pigsC P Baines, R S Szwarc, H A Ball
Journal of Bacteriology|October 1, 1996
Initial reactions in anaerobic ethylbenzene oxidation by a denitrifying bacterium, strain EB1H A Ball, H A Johnson, M Reinhard, et al.
The American Journal of Physiology|April 1, 1995
Conductance catheter measurement of left ventricular volume: evidence for nonlinearity within cardiac cycleR S Szwarc, D Laurent, P R Allegrini, et al.
Intensive Care Medicine|January 1, 1986
Role of thromboxane, prostaglandins and leukotrienes in endotoxic and septic shockH A Ball, J A Cook, W C Wise, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Metabolism and analysis of endogenous cysteinyl leukotrienesD Keppler, M Huber, W Hagmann, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1990
Leukotrienes in shock syndromes: metabolism and detection in vivoD Keppler, A Guhlmann, M Huber, et al.
Circulatory Shock|September 1, 1988
Oleic acid-induced pulmonary injury in rats: potential role of sulfidopeptide leukotrienesH A Ball, J A Cook, K M Spicer, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|August 1, 1989
Essential fatty acid-deficient rats are resistant to oleic acid-induced pulmonary injuryH A Ball, J A Cook, K M Spicer, et al.
British Journal of Clinical Pharmacology|September 6, 2000
Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphineJ Drewe, H A Ball, C Beglinger, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2000
N-[(R,R)-(E)-1-(4-chloro-benzyl)-3-(2-oxo-azepan-3-ylcarbamoyl)-allyl]-N-methyl-3,5-bis-trifluoromethyl-benzamide: an orally active neurokinin NK1/NK2 antagonistM Gerspacher, A von Sprecher, R Mah, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
British Journal of Pharmacology|October 1, 1994
Parallel tolerance between platelet cyclic GMP and preload effects of nitroglycerin in anaesthetized mini-pigsC P Baines, R S Szwarc, H A Ball
Journal of Bacteriology|October 1, 1996
Initial reactions in anaerobic ethylbenzene oxidation by a denitrifying bacterium, strain EB1H A Ball, H A Johnson, M Reinhard, et al.
The American Journal of Physiology|April 1, 1995
Conductance catheter measurement of left ventricular volume: evidence for nonlinearity within cardiac cycleR S Szwarc, D Laurent, P R Allegrini, et al.
Intensive Care Medicine|January 1, 1986
Role of thromboxane, prostaglandins and leukotrienes in endotoxic and septic shockH A Ball, J A Cook, W C Wise, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Metabolism and analysis of endogenous cysteinyl leukotrienesD Keppler, M Huber, W Hagmann, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1990
Leukotrienes in shock syndromes: metabolism and detection in vivoD Keppler, A Guhlmann, M Huber, et al.
Circulatory Shock|September 1, 1988
Oleic acid-induced pulmonary injury in rats: potential role of sulfidopeptide leukotrienesH A Ball, J A Cook, K M Spicer, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|August 1, 1989
Essential fatty acid-deficient rats are resistant to oleic acid-induced pulmonary injuryH A Ball, J A Cook, K M Spicer, et al.
British Journal of Clinical Pharmacology|September 6, 2000
Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphineJ Drewe, H A Ball, C Beglinger, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2000
N-[(R,R)-(E)-1-(4-chloro-benzyl)-3-(2-oxo-azepan-3-ylcarbamoyl)-allyl]-N-methyl-3,5-bis-trifluoromethyl-benzamide: an orally active neurokinin NK1/NK2 antagonistM Gerspacher, A von Sprecher, R Mah, et al.
Pageof 3